Kodak (KODK) Q2 2026: Operational EBITDA Jumps 300% as Advanced Materials and Print Drive Turnaround
Kodak’s transformation gains traction with a fourth straight quarter of profit and revenue growth, powered by advanced materials, chemicals, and commercial print. Balance sheet strength and segment execution signal a pivot from stabilization to targeted growth, as management leans into core competencies and specialty manufacturing. Investor focus now shifts to Kodak’s ability to scale new growth bets in pharma, battery tech, and film amid persistent input cost volatility.
Summary
- Segment Diversification Accelerates: Advanced materials and chemicals outpaced expectations, driving margin expansion.
- Balance Sheet Deleveraging: Debt reduction and cash generation have materially improved financial flexibility.
- Growth Mandate Intensifies: Management signals a shift from stabilization to targeted innovation and R&D investment.
Business Overview
Eastman Kodak is an industrial manufacturer operating two primary businesses: Commercial Print—which includes offset plates, digital presses, and consumables for print service providers—and Advanced Materials & Chemicals (AM&C), which spans motion picture film, specialty chemicals, battery coatings, and a nascent pharmaceutical platform. Kodak earns revenue by selling products and services to B2B clients globally, with a renewed focus on high-barrier, specialty manufacturing segments where it leverages deep technical know-how in coating and layering technologies.
Performance Analysis
Kodak delivered a fourth consecutive quarter of year-over-year revenue, gross profit, and operational EBITDA growth, marking a clear inflection from its legacy turnaround status. Second quarter revenue rose 18% year-over-year, with gross profit margin expanding to 26% from 19% as pricing and volumes in both core segments more than offset persistent inflation in key inputs like silver and aluminum. Operational EBITDA surged 300% year-over-year, reflecting both improved operating leverage and a structurally leaner cost base.
Segment performance was notably strong in Advanced Materials & Chemicals, which grew revenue by 40% year-over-year and benefited from a resurgence in motion picture film and specialty products. Commercial Print, now the largest division, posted 10% revenue growth amid ongoing supply chain and inflation challenges, highlighting customer loyalty and product differentiation. Balance sheet health improved materially, as net cash rose and total debt to EBITDA dropped to 1x from 23x, driven by asset sales and disciplined capital allocation.
- Advanced Materials Outperformance: AM&C revenue climbed $30 million year-over-year, led by film and specialty coatings.
- Print Segment Resilience: Commercial print grew $17 million, with broad-based demand despite global macro headwinds.
- Margin Expansion: Gross profit margin improved by 700 basis points, as pricing and mix offset commodity inflation.
Inventory rose in AM&C due to higher silver prices and pre-shutdown stockpiling, but management framed this as a strategic build rather than a demand issue. Pension income declined as expected post-CRIP plan termination, but was offset by lower interest expense and the absence of prior-year impairments.
Executive Commentary
"Kodak has delivered year-over-year improvements in key metrics for four consecutive quarters. We've done it by consistent focus on leveraging our core strengths and focusing on execution... We are building momentum. We will continue to capitalize on our strengths as an industrial manufacturer."
Jim Continenza, Executive Chairman and Chief Executive Officer
"This performance reflects our ability to navigate a challenging business environment by focusing on operational excellence and improving efficiency... Our strong performance over recent quarters has been the result of our commitment to executing our long-term plan. I'm excited about the next phase of our turnaround as we shift our focus to growth."
David Bullwinkle, Chief Financial Officer and Senior Vice President
Strategic Positioning
1. Advanced Materials & Chemicals as Growth Engine
Kodak’s reinvestment in AM&C has crystallized as a core growth pillar, with management highlighting both technical leadership in layering and coating and the ability to scale into specialty verticals. Motion picture film’s resurgence, validated by marquee directors and blockbuster releases, signals both cultural and commercial tailwinds. The pharma web store launch and battery coating CapEx show intent to capture higher-margin, tech-enabled segments.
2. Commercial Print Defends and Expands Share
Print remains the revenue anchor, with continued growth in a mature, inflation-impacted industry. Product superiority and global reach were emphasized, as management pointed to customer stickiness and delivery reliability. The segment’s ability to grow despite macro and supply chain pressures underlines operational discipline and market relevance.
3. Balance Sheet Reset Unlocks Optionality
Debt reduction and net cash generation have shifted Kodak’s financial profile, enabling both lower interest expense and renewed flexibility for R&D and strategic investment. Asset sales and pension plan changes funded term loan repayments, with management clearly signaling a preference for self-funded, high-ROI growth over leverage-driven expansion.
4. Innovation Mandate and R&D Investment
Leadership’s acquisition of an R&D division and commitment to accelerate innovation reflect a strategic pivot from cost containment to product-led growth. Focus areas—pharma, battery tech, specialty chemicals— are all higher-barrier, margin-accretive bets that leverage Kodak’s manufacturing heritage.
5. Cost Structure and Input Volatility Management
Commodity cost inflation, notably in silver and aluminum, remains a structural headwind. However, Kodak’s pricing power and inventory management have so far enabled margin expansion rather than compression, a key differentiator versus commodity-exposed peers.
Key Considerations
The quarter marks Kodak’s transition from turnaround to targeted growth, but execution risks and input volatility remain central to the story. Investors should weigh the durability of recent margin gains against the scalability of new growth bets and the sustainability of cost discipline as R&D ramps.
Key Considerations:
- AM&C Growth Sustainability: Can motion picture film and specialty chemicals maintain momentum as initial demand surges normalize?
- Print Margin Durability: Will pricing power persist if macro or competitive pressures intensify?
- R&D ROI Clarity: New investments in pharma and battery coatings are early-stage, with timelines and addressable market sizing yet to be proven.
- Commodity Risk Management: Input cost volatility could pressure margins if not offset by further pricing or mix improvements.
- Capital Allocation Discipline: Balance sheet strength offers flexibility, but growth investments must deliver measurable returns to justify pivot from stabilization mode.
Risks
Persistent commodity inflation, especially in silver and aluminum, could erode gross margins if pricing power wanes. Execution risk is elevated as Kodak transitions to growth initiatives in nascent markets like pharma and battery tech, where competition and regulatory hurdles are higher. Pension income drag and inventory increases may weigh on near-term cash flow, and any reversal in print or film demand could stall momentum. Management’s ability to deliver on R&D-led growth without overextending capital remains a critical watchpoint.
Forward Outlook
For Q3 2026, Kodak guided to:
- Continued focus on revenue and operational EBITDA growth in both AM&C and commercial print.
- Further progress in balance sheet deleveraging and cash generation.
For full-year 2026, management maintained a growth trajectory, emphasizing:
- Investment acceleration in R&D and innovation, with a shift toward higher-margin products.
Management highlighted several factors that will shape results:
- Commodity cost trends and ability to pass through price increases.
- Execution of new product launches in pharma and battery coatings.
Takeaways
Kodak’s four-quarter streak of revenue and profit growth signals a credible turnaround, but the next leg will require proof that recent gains are sustainable and that new growth bets can scale. Balance sheet strength and operational discipline provide a foundation, but input volatility and execution in new markets are key risks.
- Margin Expansion Is Real: Pricing, mix, and operational leverage are driving results, not just cost cuts.
- Growth Bets Are Early But Material: New investments in pharma and battery tech are now central to the bull case, but timelines and returns need monitoring.
- Commodity Costs and Execution Remain Key Risks: Investors should watch for any slippage in price-cost dynamics or delays in scaling new segments.
Conclusion
Kodak’s Q2 2026 results confirm a successful pivot from stabilization to growth, with advanced materials and print leading the charge. Management’s focus on innovation and balance sheet strength positions the company for further upside, but delivery in new growth areas and effective cost management will define the next phase of the turnaround.
Industry Read-Through
Kodak’s resurgence in motion picture film and specialty manufacturing reflects renewed appetite for analog and high-touch products in a digital-first world, with implications for suppliers across chemicals, coatings, and media. Commercial print’s resilience signals that differentiated product and global service are still valued even in mature, inflation-impacted sectors. Commodity cost management and inventory strategies highlighted by Kodak will be relevant for all industrial manufacturers navigating volatile input markets. Peer companies in specialty chemicals, print, and industrial tech should note Kodak’s successful balance sheet deleveraging as a potential template for funding innovation while maintaining financial discipline.